Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 1993;119(9):511-2.
doi: 10.1007/BF01686459.

The role of platinum dose intensity in the management of ovarian cancer

M Markman
Editorial

The role of platinum dose intensity in the management of ovarian cancer

M Markman. J Cancer Res Clin Oncol. 1993.
No abstract available

PubMed Disclaimer

References

    1. Advanced Ovarian Cancer Trialists Group (1991) Chemotherapy in advanced ovarian cancer: an overview of randomized clinical trials. Br Med J 303:884–893 - PMC - PubMed
    1. Andrews PA, Velury S, Mann SC, Howell SB (1988)cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 48:68–73 - PubMed
    1. Gershenson DM, Mitchell MF, Atkinson N, Silva EG, Kavanagh JJ, Morris M, Burke TW, Warner D, Wharton JT (1992) The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: “Maintenance” therapy reconsidered. Gynecol Oncol 47:7–13 - PubMed
    1. Jodrell DI, Egorin MJ, Canetta RM, Longenberg P, Goldbloom EP, Burroughs JN, Goodlow JL, Tan S, Wiltshaw E (1992) Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 10:520–528 - PubMed
    1. Kaye SB, Lewis CR, Paul J, Duncan ID, Gordon HK, Kitchener HC, Cruickshank DJ, Atkinson RJ, Soukop M, Rankin EM, Cassidy J, Davis JA, Reed NS, Crawford SM, MacLean A, Swapp GA, Sarkar TK, Kennedy JH, Symonds RP (1992) Randomized study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer. Lancet 340:329–333 - PubMed

Publication types

MeSH terms

LinkOut - more resources